These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2542329)

  • 41. Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes.
    Ramasharma K; Li CH
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3595-8. PubMed ID: 3035540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
    Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
    Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of erythropoietin receptor on erythropoietin-unresponsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Biochim Biophys Acta; 1988 Aug; 943(2):326-30. PubMed ID: 2840960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.
    Mitchell EJ; Lee K; O'Connor-McCourt MD
    Mol Biol Cell; 1992 Nov; 3(11):1295-307. PubMed ID: 1333844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T; Eto Y; Shibai H; Ogata E
    Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of mammary-derived growth factor 1 receptors and response in human mammary epithelial cell lines.
    Bano M; Kidwell WR; Lippman ME; Dickson RB
    J Biol Chem; 1990 Feb; 265(4):1874-80. PubMed ID: 2153668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Family of inhibins and activins: from endocrine to paracrine action].
    Pigny P; Dewailly D; Racadot A; Boersma A
    Ann Endocrinol (Paris); 1996; 57(5):385-94. PubMed ID: 8991102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation of FSH release by erythroid differentiation factor (EDF).
    Kitaoka M; Yamashita N; Eto Y; Shibai H; Ogata E
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1382-5. PubMed ID: 3113433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of follicle stimulating hormone receptor by erythroid differentiation factor on rat granulosa cell.
    Hasegawa Y; Miyamoto K; Abe Y; Nakamura T; Sugino H; Eto Y; Shibai H; Igarashi M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):668-74. PubMed ID: 3056399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line.
    Park JH; Vanderhoof JA; Blackwood D; Macdonald RG
    Endocrinology; 1990 Jun; 126(6):2998-3005. PubMed ID: 2161743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diminished erythropoietin-induced erythroid growth in patients with renal anemia is restored by recombinant human erythroid differentiation factor.
    Shimizu T; Kawano Y; Takaue Y; Kuroda Y
    Am J Hematol; 1994 Nov; 47(3):178-82. PubMed ID: 7942781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The existence of activin A/erythroid differentiation factor and its inhibitor in human serum: comparison of normal and chronic renal failure sera.
    Shiozaki M; Sakai R; Tabuchi M; Shinohara M; Kosaka M; Saito S; Eto Y
    Biochem Biophys Res Commun; 1992 Feb; 183(1):273-9. PubMed ID: 1543498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activin/EDF as an inhibitor of neural differentiation.
    Hashimoto M; Kondo S; Sakurai T; Etoh Y; Shibai H; Muramatsu M
    Biochem Biophys Res Commun; 1990 Nov; 173(1):193-200. PubMed ID: 2256914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
    Niinobu T; Ogawa M; Murata A; Nishijima J; Mori T
    J Exp Med; 1990 Oct; 172(4):1133-42. PubMed ID: 2170560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2.
    Iwasaki S; Tsuruoka N; Hattori A; Sato M; Tsujimoto M; Kohno M
    J Biol Chem; 1995 Mar; 270(10):5476-82. PubMed ID: 7890664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of erythroid differentiation factor (EDF) in Chinese hamster ovary cells.
    Murata M; Onomichi K; Eto Y; Shibai H; Muramatsu M
    Biochem Biophys Res Commun; 1988 Feb; 151(1):230-5. PubMed ID: 3348775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activin A/erythroid differentiation factor is induced during human monocyte activation.
    Erämaa M; Hurme M; Stenman UH; Ritvos O
    J Exp Med; 1992 Nov; 176(5):1449-52. PubMed ID: 1402687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation.
    Iwasaki S; Hattori A; Sato M; Tsujimoto M; Kohno M
    J Biol Chem; 1996 Jul; 271(29):17360-5. PubMed ID: 8663261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the action of inhibin mediated via a unique receptor?
    Robertson DM; Hertan R; Farnworth PG
    Rev Reprod; 2000 Sep; 5(3):131-5. PubMed ID: 11006162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.